Endocrine effects of chemicals: Aspects of hazard identification and human health risk assessment

Toxicology Letters

Volumn 223, Issue 3, 2013, Pages 280-286

  Dekant, Wolfgang ^a   Colnot, Thomas ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CiS Toxicology   (Chile)

Author keywords

Endocrine disruptors; Hazard assessment; Non monotonous dose response; Risk assessment

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; DAIDZEIN; ENDOCRINE DISRUPTOR; EQUOL; FOOD ADDITIVE; GENISTEIN; HORMONE RECEPTOR; INDUSTRIAL CHEMICAL; PHTHALIC ACID;

ARTICLE; BIOLOGICAL ACTIVITY; BIOTRANSFORMATION; DEVELOPMENTAL TOXICITY; DRUG SURVEILLANCE PROGRAM; ENDOCRINE FUNCTION; ENDOCRINE SYSTEM; EXPOSURE; HEALTH HAZARD; HOMEOSTASIS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

ENDOCRINE DISRUPTORS; HAZARD ASSESSMENT; NON-MONOTONOUS DOSE-RESPONSE; RISK ASSESSMENT;

ANIMALS; DECISION TREES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; GOVERNMENT AGENCIES; HUMANS; INTERNATIONAL AGENCIES; RISK ASSESSMENT; TERMINOLOGY AS TOPIC; TOXICITY TESTS;

ANIMALIA;

EID: 84888058512     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.03.022     Document Type: Article

References (77)

1. Ashby J. Endocrine disruption occurring at doses lower than those predicted by classical chemical toxicity evaluations: The case bisphenol A. Pure and Applied Chemistry 2003, 75:2167-2179.
2. Ashby J., Tinwell H., Lefevre P.A., Joiner R., Haseman J. The effect on sperm production in adult Sprague-Dawley rats exposed by gavage to bisphenol A between postnatal days 91-97. Toxicological Sciences 2003, 74:129-138.
3. Barlow S. Threshold of toxicological concern (TTC) - A tool for assessing substances of unknown toxicity present at low levels in the diet. ILSI Europe Concise Monographs Series 2005, 1-31.
4. Bars R., Broeckaert F., Fegert I., Gross M., Hallmark N., Kedwards T., Lewis D., O'Hagan S., Panter G.H., Weltje L., Weyers A., Wheeler J.R., Galay-Burgos M. Science based guidance for the assessment of endocrine disrupting properties of chemicals. Regulatory Toxicology and Pharmacology 2011, 59:37-46.
5. BfR, 2011. Joint DE. - UK position paper. Regulatory definition of an endocrine disrupter in relation to potential threat to human health. Bundesinstitut für Risikobewertun. Available at: (last accessed 12.11.2012). http://wwwbfrbundde/cm/349/regulatory_definition_of_an_endocrine_disrupter_in_relation_to_potential_threat_to_human_healthpdf.
6. Black M.B., Budinsky R.A., Dombkowski A., Cukovic D., LeCluyse E.L., Ferguson S.S., Thomas R.S., Rowlands J.C. Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicological Sciences 2012, 127:199-215.
7. Bolt H.M., Janning P., Michna H., Degen G.H. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Archives of Toxicology 2001, 74:649-662.
8. Boobis A.R., Daston G.P., Preston R.J., Olin S.S. Application of key events analysis to chemical carcinogens and noncarcinogens. Critical Reviews in Food Science and Nutrition 2009, 49:690-707.
9. Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Critical Reviews in Toxicology 2008, 38:87-96.
10. Budinsky R.A., LeCluyse E.L., Ferguson S.S., Rowlands J.C., Simon T. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran. Toxicological Sciences 2010, 118:224-235.
11. Carmichael N., Bausen M., Boobis A.R., Cohen S.M., Embry M., Fruijtier-Polloth C., Greim H., Lewis R., Bette Meek M.E., Mellor H., Vickers C., Doe J. Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview. Critical Reviews in Toxicology 2011, 41:175-186.
12. Chen A., Rogan W.J. Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annual Review of Nutrition 2004, 24:33-54.
13. Connor K.T., Aylward L.L. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2006, 9:147-171.
14. COT, 2012. Regulatory definition of endocrine disruptors. Committee on Toxicity. Available at: (last accessed 12.11.2012). http://cotfoodgovuk/pdfs/tox201015pdf.
15. Counts J.L., Goodman J.I. Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. Regulatory Toxicology and Pharmacology 1995, 21:418-421.
16. Courant F., Antignac J.P., Laille J., Monteau F., Andre F., Le Bizec B. Exposure assessment of prepubertal children to steroid endocrine disruptors. 2. Determination of steroid hormones in milk, egg, and meat samples. Journal of Agricultural and Food Chemistry 2008, 56:3176-3184.
17. Courant F., Antignac J.P., Maume D., Monteau F., Andre F., Le Bizec B. Determination of naturally occurring oestrogens and androgens in retail samples of milk and eggs. Food Additives and Contaminants 2007, 24:1358-1366.
18. Deschl U., Kittel B., Rittinghausen S., Morawietz G., Kohler M., Mohr U., Keenan C. The value of historical control data-scientific advantages for pathologists, industry and agencies. Toxicologic Pathology 2002, 30:80-87.
19. Divi R.L., Chang H.C., Doerge D.R. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochemical Pharmacology 1997, 54:1087-1096.
20. Dybing E., O'Brien J., Renwick A.G., Sanner T. Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic - an overview. Toxicology Letters 2008, 180:110-117.
21. EC-Weybridge, 1996. European workshop on the impact of endocrine disrupters on human health and wildlife. Report of Proceedings, Weybridge, United Kingdom, 2-4 December.
22. EDSTAC, 1998. Endocrine Disruptor Screening and Testing Advisory Committee Final Report 1998. Available at: (last accessed 12.11.2012). http://wwwepagov/endo/pubs/edspoverview/finalrpthtm.
23. EFSA, 2005. Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to Bis(2-ethylhexyl)phthalate (DEHP) for use in food contact materials.
24. EFSA, 2010. Scientific opinion on bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of bisphenol A of the EFSA Panel on Food contact materials, enzymes, flavourings and processing aids (CEF) on request from the European Commission, Questions No EFSA-Q-2009-00864, EFSA-Q-2010-01023 and EFSA-Q-2010-00709, adopted on 23rd September 2010. EFSA Journal 8(9):1929, 1-116.
25. EMA, 2006. European Medicines Agency-CHMP Guideline on the Limits of Genotoxic Impurities. Available at: (last accessed 23.11.2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf.
26. EU, 2008. European Union Risk Assessment Report. Bisphenol A, CAS No: 80-05-7, Addendum 2008. Institute for Health and Consumer Protection, European Chemicals Bureau, European Commission Joint Research Centre, 3rd Priority List, Luxembourg: Office for Official Publications of the European Communities.
27. EU-SCCNFP, 2004. Opinion of the Scientific Committee on Cosmetic and non-food products intended for consumers concerning 4-Methylbenzylidene Camphor Colipa n°S60 adopted during the 28th plenary meeting of 25 May 2004.
28. FDA, 2007. Redbook 2000 - Guidance for industry and other stakeholders, toxicological principles for the safety assessment of food ingredients US Department of Health and Human Services, Food and Drug Administration Center for Food Safety and Applied Nutrition, July 2000; Updated July 2007.
29. FDA Draft Assessment of Bisphenol A for Use in Food Contact Applications 2008, US Food and Drug Administration.
30. FDA, 2008. Guidance for industry: Genotoxic and carcinogenic impurities in drug substances and products - recommended approaches. US Food and Drug Administration. Available at: (last accessed 23.11.2012). http://wwwfdagov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079235pdf.
31. Gastel J.A., Sutter T.R. Biologically bounded risk assessment for receptor-mediated nongenotoxic carcinogens. Regulatory Toxicology and Pharmacology 1995, 22:273-282.
32. Gelbke H.P., Hofmann A., Owens J.W., Freyberger A. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration. Archives of Toxicology 2007, 81:227-250.
33. Gelbke H.P., Kayser M., Poole A. OECD test strategies and methods for endocrine disruptors. Toxicology 2004, 205:17-25.
34. Goodman J.E., McConnell E.E., Sipes I.G., Witorsch R.J., Slayton T.M., Yu C.J., Lewis A.S., Rhomberg L.R. An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Critical Reviews in Toxicology 2006, 36:387-457.
35. Goodman J.E., Witorsch R.J., McConnell E.E., Sipes I.G., Slayton T.M., Yu C.J., Franz A.M., Rhomberg L.R. Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Critical Reviews in Toxicology 2009, 39:1-75.
36. Heger N.E., Hall S.J., Sandrof M.A., McDonnell E.V., Hensley J.B., McDowell E.N., Martin K.A., Gaido K.W., Johnson K.J., Boekelheide K. Human fetal testis xenografts are resistant to phthalate-induced endocrine disruption. Environmental Health Perspectives 2012, 120:1137-1143.
37. Hennes E.C. An overview of values for the threshold of toxicological concern. Toxicology Letters 2012, 211:296-303.
38. Johnson K.J., Heger N.E., Boekelheide K. Of mice and men (and rats): phthalate-induced fetal testis endocrine disruption is species-dependent. Toxicological Sciences 2012, 129:235-248.
39. Karbe E., Williams G.M., Lewis R.W., Kimber I., Foster P.M. Distinguishing between adverse and non-adverse effects. Session summary. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft fur Toxikologische Pathologie 2002, 54:51-55.
40. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environmental Health Perspectives 1996, 104(Suppl. 4):715-740.
41. Klimisch H.J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regulatory Toxicology and Pharmacology 1997, 25:1-5.
42. Kortenkamp, A., Martin, O., Faust, M., Evans, R., McKinlay, R., Orton, F., Rosivatz, E., 2011. State of the art assessment of endocrine disrupters. Final Report. Available at: (last accessed 16.11.2012). http://eceuropaeu/environment/endocrine/documents/4_SOTAEDCFinalReportV36Feb12pdf.
43. Kroes R., Kozianowski G. Threshold of toxicological concern (TTC) in food safety assessment. Toxicology Letters 2002, 127:43-46.
44. Kwack S.J., Kim K.B., Kim H.S., Yoon K.S., Lee B.M. Risk assessment of soybean-based phytoestrogens. Journal of Toxicology and Environmental Health Part A 2009, 72:1254-1261.
45. Lewis R.W., Billington R., Debryune E., Gamer A., Lang B., Carpanini F. Recognition of adverse and nonadverse effects in toxicity studies. Toxicologic Pathology 2002, 30:66-74.
46. Marx-Stoelting P., Pfeil R., Solecki R., Ulbrich B., Grote K., Ritz V., Banasiak U., Heinrich-Hirsch B., Moeller T., Chahoud I., Hirsch-Ernst K.I. Assessment strategies and decision criteria for pesticides with endocrine disrupting properties relevant to humans. Reproductive Toxicology 2011, 31:574-584.
47. Medlock K.L., Branham W.S., Sheehan D.M. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proceedings of the Society for Experimental Biology and Medicine 1995, 208:67-71.
48. Medlock K.L., Branham W.S., Sheehan D.M. The effects of phytoestrogens on neonatal rat uterine growth and development. Proceedings of the Society for Experimental Biology and Medicine 1995, 208:307-313.
49. Melnick R., Lucier G., Wolfe M., Hall R., Stancel G., Prins G., Gallo M., Reuhl K., Ho S.M., Brown T., Moore J., Leakey J., Haseman J., Kohn M. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environmental Health Perspectives 2002, 110:427-431.
50. Mitchell R.T., Childs A.J., Anderson R.A., van den Driesche S., Saunders P.T., McKinnell C., Wallace W.H., Kelnar C.J., Sharpe R.M. Do phthalates affect steroidogenesis by the human fetal testis? Exposure of human fetal testis xenografts to di-n-butyl phthalate. Journal of Clinical Endocrinology and Metabolism 2012, 97:E341-E348.
51. Munro I.C., Renwick A.G., Danielewska-Nikiel B. The Threshold of Toxicological Concern (TTC) in risk assessment. Toxicology Letters 2008, 180:151-156.
52. NRDC, 1998. Endocrine disruptors. National Resources Defence Council. Available at: (last accessed 12.11.2012). http://wwwnrdcorg/health/effects/qendocasp.
53. OECD, 2002. Conceptual framework for the testing and assessment of endocrine disrupting chemicals. Organisation for Economic Co-operation and Development. Available at: (last accessed 12.11.2012). http://wwwoecdorg/document/58/0,3343,en_2649_34377_2348794_1_1_1_1,00html.
54. OECD, 2008. Guideline for the Testing of Chemicals - TG 407. Organisation for Economic Co-operation and Development. Available at: (last accessed 25.02.2013). http://wwwoecdorg/env/ehs/testing/oecdguidelinesforthetestingofchemicalshtm.
55. OECD, 2010. Draft guidance document 116 on the design and conduct of chronic toxicity and carcinogenicity studies, supporting TG 451, 452 and 453. Organisation for Economic Co-operation and Development. Available at: (last accessed 23.11.2012). http://wwwoecdorg/chemicalsafety/testingofchemicals/46766792pdf.
56. OECD, 2010. Guidance document on the assessment of chemicals for endocrine disruption, version 9. Organisation for Economic Co-operation and Development. Available at: (last accessed 23.11.2012). http://wwwoecdorg/chemicalsafety/testingofchemicals/46436593pdf.
57. Phillips K.P., Foster W.G., Leiss W., Sahni V., Karyakina N., Turner M.C., Kacew S., Krewski D. Assessing and managing risks arising from exposure to endocrine-active chemicals. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2008, 11:351-372.
58. Poland A. Reflections on risk assessment of receptor-acting xenobiotics. Regulatory Toxicology and Pharmacology 1997, 26:41-43.
59. Renwick A.G., Barlow S.M., Hertz-Picciotto I., Boobis A.R., Dybing E., Edler L., Eisenbrand G., Greig J.B., Kleiner J., Lambe J., Muller D.J., Smith M.R., Tritscher A., Tuijtelaars S., van den Brandt P.A., Walker R., Kroes R. Risk characterisation of chemicals in food and diet. Food and Chemical Toxicology 2003, 41:1211-1271.
60. Rhomberg L.R., Goodman J.E. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?. Regulatory Toxicology and Pharmacology 2012, 64:130-133.
61. Safe S.H. Environmental and dietary estrogens and human health: is there a problem?. Environmental Health Perspectives 1995, 103:346-351.
62. Safe S.H. Endocrine disruptors and human health - is there a problem? An update. Environmental Health Perspectives 2000, 108:487-493.
63. Sharpe R.M. Is it time to end concerns over the estrogenic effects of bisphenol A?. Toxicological Sciences 2010, 114:1-4.
64. Singh P., Kumar R., Sabapathy S.N., Bawa A.S. Functional and edible uses of soy protein products. Comprehensive Reviews in Food Science and Food Safety 2008, 7:14-28.
65. Tyl R.W. The presence (or not) of effects from low oral doses of BPA. Journal of Toxicological Sciences 2009, 34:587-588.
66. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., Waechter J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicological Sciences 2008, 104:362-384.
67. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews 2012, 33:378-455.
68. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocrine Reviews 2009, 30:75-95.
69. vom Saal F.S., Akingbemi B.T., Belcher S.M., Crain D.A., Crews D., Guidice L.C., Hunt P.A., Leranth C., Myers J.P., Nadal A., Olea N., Padmanabhan V., Rosenfeld C.S., Schneyer A., Schoenfelder G., Sonnenschein C., Soto A.M., Stahlhut R.W., Swan S.H., Vandenberg L.N., Wang H.S., Watson C.S., Welshons W.V., Zoeller R.T. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicological Sciences 2010, 115:612-613. author reply 614-620.
70. Wandall B., Hansson S.O., Ruden C. Bias in toxicology. Archives of Toxicology 2007, 81:605-617.
71. Whitmire M.L., Bryan P., Henry T.R., Holbrook J., Lehmann P., Mollitor T., Ohorodnik S., Reed D., Wietgrefe H.D. Nonclinical dose formulation analysis method validation and sample analysis. The AAPS Journal 2010, 12:628-634.
72. WHO/IPCS, 2002. Global assessment of the state-of-the-science of endocrine disruptors. WHO/PCS/EDC/02.2, World Health Organisation, Geneva, pp. 180.
73. WHO/IPCS, 2004. Exposure assessment and risk assessment terminology. Available at: (last accessed 12.11.2012). http://wwwwhoint/ipcs/methods/harmonization/areas/terminology/en/indexhtml.
74. Wiltse J.A., Dellarco V.L. U.S. Environmental Protection Agency's revised guidelines for carcinogen risk assessment: evaluating a postulated mode of carcinogenic action in guiding dose-response extrapolation. Mutation Research 2000, 464:105-115.
75. Witorsch R.J. Endocrine disruptors: can biological effects and environmental risks be predicted?. Regulatory Toxicology and Pharmacology 2002, 36:118-130.
76. Yamasaki K., Sawaki M., Noda S., Imatanaka N., Takatsuki M. Subacute oral toxicity study of ethynylestradiol and bisphenol A, based on the draft protocol for the Enhanced OECD Test Guideline no. 407. Archives of Toxicology 2002, 76:65-74.
77. Zoeller R.T., Brown T.R., Doan L.L., Gore A.C., Skakkebaek N.E., Soto A.M., Woodruff T.J., Vom Saal F.S. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012, 153:4097-4110.